0045 GMT - Fisher & Paykel's bulls at Canaccord Genuity see the dual-listed medical-device maker as a potential beneficiary of U.S. vaccination policy. The main earnings driver of the company's latest guidance upgrade is the adoption of high-flow nasal cannula in hospitals, the Canaccord analysts tell clients in a note. They also observe that, after an early peak in the U.S. influenza season, hospitalizations seem to have risen so far in 2026. Pointing to a backdrop of fewer childhood vaccine recommendations and lower overall vaccination rates, the analysts see potential U.S. tailwinds for Fisher & Paykel. Canaccord keeps a buy rating and A$37.50 target price on its Australia-listed stock, which is up 2.3% at A$33.68. ([email protected])

0035 GMT - Navigator Global's M&A optionality and strong pipeline of Blue Owl-originated opportunities help keep Macquarie bullish on the Australian alternative-asset manager. Navigator's December-half earnings were 30% stronger than consensus, driving Macquarie's analysts to raise their EPS forecasts for the next three fiscal years by between 10% and 20%. They tell clients in a note that they are increasingly confident about the medium-term outlook for Navigator's strategic distributions. Macquarie raises its target price 21% to A$3.17 and keeps an outperform rating on the stock, which is down 3.2% at A$2.71. ([email protected])

0025 GMT - Megaport's bull at Macquarie thinks the pace of the connectivity service provider's growth means its stock looks cheap at 13 times earnings. A note from one of the investment bank's analysts acknowledges concerns over reinvestment-driven cost growth but points to what they say is a structural growth story in a large and fast-growing market. Capital allocation to date has been validated with strong unit economics, the note says. There are also synergies from acquisitions and strong potential cross-selling opportunities, the analyst adds. Macquarie keeps an outperform rating on the stock and lifts its target price 7.4% to A$23.30. Shares are down 3.8% at A$7.66.([email protected])

0023 GMT - HMC Capital's bull at UBS doesn't see the property and infrastructure investor hitting its medium-term target for assets under management. HMC Capital wants A$50 billion of AUM. Analyst Solomon Zhang thinks A$27 billion by FY 2030 is more likely, driven by real estate and private credit. "We ascribe minimal growth to Digital Infrastructure and Energy Transition beyond what is secured today, and view these verticals as upside," UBS says. It would like HMC to drop the medium-term AUM goal, given it's not wholly within the company's control. UBS lowers its price target on HMC Capital by 39% to A$4.00/share. HMC falls 4.2% to A$2.835 following its 1H result today. The stock is down some 71% over the past 12 months. ([email protected]; @dwinningWSJ)

0003 GMT - Nib's valuation appeals to UBS analysts, but they stay cautious on the Australian health insurer due to rising margin risks. Maintaining a neutral rating on the stock, the UBS analysts tell clients in a note that earnings visibility surrounding Nib's key Australian residents business has become more opaque due to softer policy growth and accelerating claims-paid inflation. Margin risks look skewed to the downside despite the insurer's tighter cost control, they add. UBS trims its target price 1.4% to A$7.20. Shares are down 2.5% at A$6.36. ([email protected])

0000 GMT - Aussie Broadband's bull sees the Australian telecommunications challenger becoming the third-largest provider of services on the country's national broadband network by the year's end. Jefferies analyst John Campbell tells clients in a note that Aussie Broadband's M&A activity is materially embellishing momentum that nonetheless remains intact on an underlying organic basis. 1H underlying net profit fell short of Jefferies' forecasts, but Campbell says that this is offset by strong guidance for the full fiscal year. Jefferies keeps a buy rating on the stock and cuts its target price 3.1% to A$6.20. Shares are down 1.0% at A$5.04. ([email protected])

2358 GMT - Woodside Energy had strongly signaled its annual earnings ahead of time. But that doesn't mean there aren't outstanding questions. Jarden analyst Nik Burns says investors had hoped the company would name its next CEO today. That didn't happen but Woodside is on track to appoint someone this quarter. "With growth projects all on track, we expect focus on Louisiana LNG sell-downs, Sangomar production outlook in 2026 now that it's off plateau, and state of LNG markets given Woodside has 8 million tons per annum of LNG for sale from Louisiana," says Jarden. Sangomar is Woodside's oil project in Senegal and Louisiana LNG is its gas-export facility under construction in the U.S. Woodside rises 1.7% to A$27.57 following its annual result. ([email protected]; @dwinningWSJ)

2347 GMT - Mall owner Scentre's maiden guidance for its 2026 earnings underwhelms, triggering a 2.6% drop in its share price to A$3.69 today. Scentre forecast funds from operations--a smoothed measure of operating cash flow that excludes depreciation, amortization and gains on asset sales--of at least 23.73 Australian cents/security. The guidance suggests minimum growth of 4.0% on the 22.82 cents achieved in 2025. Jarden says the forecast missed consensus hopes by 2.5%. Scentre's distribution guidance of 18.43 cents/security was stronger than Jarden expected, but less than the 18.60 cents penciled in by the market. Jarden rated Scentre at underweight with a A$4.40/share price target ahead of its annual result. ([email protected]; @dwinningWSJ)

2332 GMT -- Dalrymple Bay Infrastructure reports annual funds from operations materially above consensus, although shareholder returns are "the real story" of DBI's 2025 results, Citi analyst Samuel Seow says. The company's 2H distribution is roughly 5% higher than consensus, and its 1H 2026 guidance is roughly 10% higher. "Commentary suggests payout ratio increased to the upper end of 60-80% range," says Seow. He reckons the stock's recent strength appears justifiable given materially higher payouts. DBI is up 9.0% at A$5.56 on the 1H result. It is up more than 50% since the start of last year. ([email protected])

It's been a strong earnings season for major miners, with most beating Ebitda and free cash flow forecasts, says Jefferies analyst Christopher LaFemina. Among the large diversified miners, Jefferies views Glencore, Anglo American, Teck Resources and Vale as being the best value at current prices. It is more cautious on Rio Tinto and BHP, he says. "We continue to believe that a rising tide will lift all boats in mining due to demand for hard assets with low risk of obsolescence," says LaFemina. ([email protected]; @RhiannonHoyle)

2302 GMT - Monadelphous delivers a stellar half-year result, according to Citi analyst William Park. In a note, he says the company's 1H report "demonstrated why it is considered to be a high-quality contractor with razor-sharp focus on risk, capacity and cost management." The result includes a strong earnings beat and higher-than-expected FY 2026 revenue guidance. Importantly, "there was no cautious comment on MND's outlook slide. This is significant given MND is known for being very conservative," Park says. He expects shares to rise meaningfully. Citi has a buy rating and A$28.75 target on Monadelphous. The stock ended Monday at A$30.62. ([email protected]; @RhiannonHoyle)

(END) Dow Jones Newswires